---
figid: PMC7477297__fpsyg-11-02139-g003
figtitle: Hypothetical OT signaling pathways targeting the nucleus and mitochondria
  in the cardiac cells
organisms:
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Canis lupus familiaris
- Salmonella enterica subsp. enterica serovar Typhimurium
- Limosilactobacillus reuteri
- Homo sapiens
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Canis lupus familiaris
- Oryctolagus cuniculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7477297
filename: fpsyg-11-02139-g003.jpg
figlink: pmc/articles/PMC7477297/figure/F3/
number: F3
caption: Schematic diagram of hypothetical OT signaling pathways targeting the nucleus
  and mitochondria in the cardiac cells. Multiple mechanisms stimulated by the OTR
  can contribute to the beneficial effects in cardiac cells. OTR activates GTP-binding
  proteins of the G alpha q/11 class, which stimulate phospholipase C activity, IP3
  generation, and release of calcium from intracellular stores. Changes in calcium
  stimulate ANP release from cardiac atrial deposits and subsequent activation of
  particulate guanylyl cyclase and cGMP production. Activation of PI3K signaling pathway
  is also involved in cardioprotection. This results in phosphorylation and activation
  of AKT and NOS activation and NO production. NO stimulates soluble guanylyl cyclase
  also producing cGMP. cGMP has been linked to activate the mitochondrial mKATP channel.
  Activation of the PI3K/ERK1/2 pathways also leads to phosphorylation and inactivation
  of GSK. Inhibition of GSK has also been reported to inhibit the mPTP. Activation
  of the mKATP channels stimulates the inhibitory phosphorylation of GSK-3b and inhibits
  ROS production. NO also induces protein S-nitrosylation (SNO). SNO of the L-type
  calcium channel reduces calcium entry and the amount of calcium that enters the
  mitochondria. This inhibits the effect of calcium on the activation of the mPTP.
  SNO effects on complex I results in lowered production of ROS. In effect, these
  beneficial signaling pathways cause reduction in calcium and ROS triggers for mPTP.
  In addition, cGMP stimulates cGKIα, which interacts with mitochondrial large conductance
  calcium-activated potassium channel, stimulating potassium influx in mitochondria.
  This effect may lead closure of the mPTP and cardioprotection. ANP, atrial natriuretic
  peptide; NO, nitric oxide; OT, oxytocin; OTR, oxytocin receptor; ROS, reactive oxygen
  species. AC, adenylate cyclase; AMPK, AMP-activated protein kinase; AKT, protein
  kinase B; ANP, atrial natriuretic peptide; CaM, calmodulin; CaMKK, Ca2+ calmodulin-dependent
  protein kinase kinase; CaMK, Ca2+/calmodulin-dependent protein kinase; cGKI, cGMP-dependent
  protein kinase type Iα; cGMP, cyclic guanosine monophosphate (DAG) diacyl glycerol;
  (EC) endothelial cells; eEF2, elongation factor 2; ERK, extracellular signal-regulated
  kinases; GATA4, GATA binding protein 4; GSK3β, glycogen synthase kinase 3 beta;
  IP3, inositol 1,4,5-trisphosphate; JAK, Janus kinase; mBK, mitochondrial BKCa channel;
  MEK5, mitogen-activated protein kinase kinase 5; mKATP, mitochondrial KATP channels;
  MnSOD, manganese superoxide dismutase; NFAT, nuclear factor of activated T-cells;
  NOS, NO synthase; NPR-A, natriuretic peptide receptor A; pGC, particulate guanylyl
  cyclase; PIP2, phosphatidylinositol 4,5-bisphosphate; PKA, protein kinase A; PKC,
  protein kinase C; PKG, protein kinase G; PLC, phospholipase C; PI3K, phosphatidyl-3
  kinase; mPTP, mitochondrial permeability transition pore; SNO, S-nitrosothiol; STAT3,
  signal transducer and activator of transcription 3; TKs, receptor tyrosine kinases.
papertitle: The Role of Oxytocin in Cardiovascular Protection.
reftext: Marek Jankowski, et al. Front Psychol. 2020;11:2139.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9026848
figid_alias: PMC7477297__F3
figtype: Figure
redirect_from: /figures/PMC7477297__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7477297__fpsyg-11-02139-g003.html
  '@type': Dataset
  description: Schematic diagram of hypothetical OT signaling pathways targeting the
    nucleus and mitochondria in the cardiac cells. Multiple mechanisms stimulated
    by the OTR can contribute to the beneficial effects in cardiac cells. OTR activates
    GTP-binding proteins of the G alpha q/11 class, which stimulate phospholipase
    C activity, IP3 generation, and release of calcium from intracellular stores.
    Changes in calcium stimulate ANP release from cardiac atrial deposits and subsequent
    activation of particulate guanylyl cyclase and cGMP production. Activation of
    PI3K signaling pathway is also involved in cardioprotection. This results in phosphorylation
    and activation of AKT and NOS activation and NO production. NO stimulates soluble
    guanylyl cyclase also producing cGMP. cGMP has been linked to activate the mitochondrial
    mKATP channel. Activation of the PI3K/ERK1/2 pathways also leads to phosphorylation
    and inactivation of GSK. Inhibition of GSK has also been reported to inhibit the
    mPTP. Activation of the mKATP channels stimulates the inhibitory phosphorylation
    of GSK-3b and inhibits ROS production. NO also induces protein S-nitrosylation
    (SNO). SNO of the L-type calcium channel reduces calcium entry and the amount
    of calcium that enters the mitochondria. This inhibits the effect of calcium on
    the activation of the mPTP. SNO effects on complex I results in lowered production
    of ROS. In effect, these beneficial signaling pathways cause reduction in calcium
    and ROS triggers for mPTP. In addition, cGMP stimulates cGKIα, which interacts
    with mitochondrial large conductance calcium-activated potassium channel, stimulating
    potassium influx in mitochondria. This effect may lead closure of the mPTP and
    cardioprotection. ANP, atrial natriuretic peptide; NO, nitric oxide; OT, oxytocin;
    OTR, oxytocin receptor; ROS, reactive oxygen species. AC, adenylate cyclase; AMPK,
    AMP-activated protein kinase; AKT, protein kinase B; ANP, atrial natriuretic peptide;
    CaM, calmodulin; CaMKK, Ca2+ calmodulin-dependent protein kinase kinase; CaMK,
    Ca2+/calmodulin-dependent protein kinase; cGKI, cGMP-dependent protein kinase
    type Iα; cGMP, cyclic guanosine monophosphate (DAG) diacyl glycerol; (EC) endothelial
    cells; eEF2, elongation factor 2; ERK, extracellular signal-regulated kinases;
    GATA4, GATA binding protein 4; GSK3β, glycogen synthase kinase 3 beta; IP3, inositol
    1,4,5-trisphosphate; JAK, Janus kinase; mBK, mitochondrial BKCa channel; MEK5,
    mitogen-activated protein kinase kinase 5; mKATP, mitochondrial KATP channels;
    MnSOD, manganese superoxide dismutase; NFAT, nuclear factor of activated T-cells;
    NOS, NO synthase; NPR-A, natriuretic peptide receptor A; pGC, particulate guanylyl
    cyclase; PIP2, phosphatidylinositol 4,5-bisphosphate; PKA, protein kinase A; PKC,
    protein kinase C; PKG, protein kinase G; PLC, phospholipase C; PI3K, phosphatidyl-3
    kinase; mPTP, mitochondrial permeability transition pore; SNO, S-nitrosothiol;
    STAT3, signal transducer and activator of transcription 3; TKs, receptor tyrosine
    kinases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nppa
  - Npr1
  - Oxtr
  - Stat3
  - Pgc
  - Gnaq
  - Sag
  - ras
  - Hras
  - Kras
  - Rem1
  - Raf1
  - Hspg2
  - gs
  - Gs
  - Mdk
  - Map2k1
  - Map2k2
  - ac
  - Akt1
  - Pik3r1
  - Mapk7
  - Eef2
  - Ephb2
  - Mapk1
  - Mapk3
  - Calm1
  - Tmem50a
  - Nfatc2
  - Nos3
  - Vegfa
  - Bc1
  - Bc1-ps1
  - Igkv1-136
  - Sod2
  - Mef2c
  - Gata4
  - Elk1
  - Fos
  - Jun
  - Nkx2-5
  - Srgn
  - Rps6kb1
  - Gsk3b
  - pc
  - pk
  - Prkg1
  - sno
  - Skil
  - Med23
  - Sbno2
  - Sbno1
  - Prkce
  - Rnase2
  - Prkcg
  - Pik3cg
  - Ephb1
  - Calm2
  - Nfat5
  - Kcnh8
  - Tmprss5
  - Prkaa2
  - Gucy1b1
  - Gucy1b2
  - Gucy1a1
  - NPPA
  - STAT3
  - PGC
  - RAF1
  - EEF2
  - MAPK1
  - VEGFA
  - MEF2C
  - GATA4
  - ELK1
  - FOS
  - JUN
  - NKX2-5
  - GSK3B
  - PC
  - CALM2
  - NOS3
  - NPR1
  - OXTR
  - GNAQ
  - KRAS
  - HRAS
  - NRAS
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - MKKS
  - MKS1
  - GNAS
  - GNAL
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK7
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - EPHB2
  - MAPK3
  - CALM1
  - CALM3
  - KRIT1
  - CAMKMT
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - ENO4
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - SOD2
  - KCNH4
  - KCNH8
  - APRT
  - MFAP1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SGCB
  - GUCY1A2
  - GUCY1A1
  - GUCY1B1
  - GUCY1B2
  - RPS6KB1
  - RPS6KB2
  - PRKG1
  - SKIL
  - SBNO2
  - SBNO1
  - Anp
  - Oct-TyrR
  - pgc
  - Galphaq
  - CG17760
  - CG30054
  - Ras64B
  - Ras85D
  - hop
  - bsk
  - Raf
  - ot
  - norpA
  - sl
  - Plc21C
  - Cdc27
  - Dsor1
  - Mtk
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - eEF2
  - CG4849
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Erk7
  - rl
  - Cam
  - CaMKII
  - NFAT
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - BC1
  - Mef2
  - pnr
  - kay
  - Jra
  - tin
  - Amph
  - SNF4Agamma
  - AMPKalpha
  - ec
  - Gycalpha99B
  - Pkg21D
  - S6k
  - for
  - sgg
  - Axn
  - gskt
  - Snoo
  - CG43051
  - AMP
  - Glucose
  - CGMP
  - MPTP
  - MEF-2C
  - hypertrophic
---
